Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Hims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food and Drug Administration (FDA) officially resolved the semaglutide shortage.

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an ... compared to a 0.1% drop in the placebo group. The result caused the trial to meet its primary endpoint.